WC
GMED icon

Wexford Capital’s Globus Medical GMED Stock Holding History

Wexford Capital’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,200
Closed -$109K – 333
2020
Q3 		$109K Buy
2,200
+1,100
+100% +$56.7K 0.03% 121
2020
Q2 		$52K Buy
+1,100
New +$53.1K 0.01% 158

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Wexford Capital's GMED Position: Q4 2020 in Review

Wexford Capital sold out of Globus Medical (GMED) in Q4 2020, closing a stake of 2,200 shares — an estimated $109K sold.

Wexford Capital first reported a position in GMED in Q2 2020 and held it in 2 quarters. The position peaked at $109K in Q3 2020. 348 funds tracked by Wall St. Rank hold GMED as of Q4 2020.

  • Wexford Capital reported no remaining Globus Medical position as of Q4 2020 after selling out during the quarter.
  • Wexford Capital sold 2,200 Globus Medical shares in Q4 2020, an estimated $109K.
  • Wexford Capital first reported a position in Globus Medical in Q2 2020 and held it in 2 quarters.
  • Wexford Capital's Globus Medical position peaked at $109K in Q3 2020.
  • 348 funds tracked by Wall St. Rank held Globus Medical as of Q4 2020.

Based on Wexford Capital's 13F filing for Q4 2020, filed 16 Feb 2021.